ENVOY MEDICAL, INC. Research and Development Expense
ENVOY MEDICAL, INC. (COCH) reported Research and Development Expense of $3.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- ENVOY MEDICAL, INC. research and development expense for the quarter ending 2026-06-30 was $3.13M, a 26.04% increase year-over-year.
- ENVOY MEDICAL, INC. research and development expense for the quarter ending 2026-03-31 was $3.64M, a 32.53% increase year-over-year.
- ENVOY MEDICAL, INC. research and development expense for the quarter ending 2025-12-31 was $4.55M, a 84.26% increase year-over-year.
- ENVOY MEDICAL, INC. research and development expense for the quarter ending 2025-09-30 was $2.70M, a 2.07% decline year-over-year.
- ENVOY MEDICAL, INC. research and development expense for fiscal 2023 was $8.96M, a 80.02% increase from fiscal 2022.
- ENVOY MEDICAL, INC. research and development expense for fiscal 2022 was $4.97M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.13M 10-Q · filed 2026-08-10 | $6.77M 10-Q · filed 2026-08-10 | $11.33M derived: sum of 3 quarters · filed 2026-08-10 | $14.03M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $3.64M POS AM · filed 2026-06-12 | $8.20M derived: sum of 2 quarters · filed 2026-06-12 | $10.89M derived: sum of 3 quarters · filed 2026-06-12 | $13.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $4.55M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $7.25M derived: sum of 2 quarters · filed 2026-06-12 | $9.74M derived: sum of 3 quarters · filed 2026-08-10 | $12.49M POS AM · filed 2026-06-12 |
| 2025-09-30 | $2.70M 10-Q · filed 2025-11-10 | $5.18M derived: sum of 2 quarters · filed 2026-08-10 | $7.93M 10-Q · filed 2025-11-10 | $10.40M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.48M 10-Q · filed 2026-08-10 | $5.23M 10-Q · filed 2026-08-10 | $7.70M derived: sum of 3 quarters · filed 2026-08-10 | $10.46M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.75M POS AM · filed 2026-06-12 | $5.22M derived: sum of 2 quarters · filed 2026-06-12 | $7.98M derived: sum of 3 quarters · filed 2026-06-12 | $10.57M derived: sum of 4 quarters · filed 2026-06-12 |
| 2024-12-31 | $2.47M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $5.23M derived: sum of 2 quarters · filed 2026-06-12 | $7.82M derived: sum of 3 quarters · filed 2026-06-12 | $10.18M POS AM · filed 2026-06-12 |
| 2024-09-30 | $2.76M 10-Q · filed 2025-11-10 | $5.35M derived: sum of 2 quarters · filed 2025-11-10 | $7.71M 10-Q · filed 2025-11-10 | $10.76M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $2.59M 10-Q · filed 2025-07-31 | $4.95M 10-Q · filed 2025-07-31 | $8.01M derived: sum of 3 quarters · filed 2025-07-31 | $9.86M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $2.36M 10-Q · filed 2025-05-01 | $5.42M derived: sum of 2 quarters · filed 2025-05-01 | $7.26M derived: sum of 3 quarters · filed 2025-05-01 | $9.42M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.91M derived: sum of 2 quarters · filed 2025-03-31 | $7.06M derived: sum of 3 quarters · filed 2025-03-31 | $8.96M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.85M 10-Q · filed 2024-11-14 | $4.00M derived: sum of 2 quarters · filed 2024-11-14 | $5.90M 10-Q · filed 2024-11-14 | $7.37M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $2.15M 10-Q · filed 2024-08-12 | $4.08M 10-Q · filed 2024-08-12 | $5.52M derived: sum of 3 quarters · filed 2024-08-12 | $6.46M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.93M 10-Q · filed 2024-05-15 | $3.37M derived: sum of 2 quarters · filed 2024-05-15 | $4.30M derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.44M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | $2.38M derived: sum of 2 quarters · filed 2024-04-01 | $4.97M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $935.00K 10-Q/A · filed 2024-01-17 | $3.53M 10-Q/A · filed 2024-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |